The National Institute for Infectious Diseases (NICD) has confirmed that 4,344 new cases of Covid-19 have been identified in South Africa in the last 24 hours.
This brings the total number of laboratory-confirmed cases to 3,891,793.
The country also reported two new deaths in the last 24-48 hours. To date, the total number of deaths from Covid-19 is 100,755.
As according to NICDthe total number of recoveries is now 3,710,696, with a recovery rate of 95.3%.
This is a significant decrease compared to On Saturday, May 14, 8015 cases were registered.
Covid-19: global developments
Fever deaths in North Korea
North Korea on Sunday reported 15 additional deaths from the “fever” days after officially confirming its first-ever Covid-19 cases and ordering nationwide lockdowns.
The outbreak, which leader Kim Jong-un says is causing “great shocks,” is putting a country with one of the world’s worst health care systems on the brink of potential disaster.
North Korea has no Covid-19 vaccines, antivirals, or mass testing facilities.
Spain and Morocco to reopen land borders
Spain’s foreign minister said on Wednesday that Rabat and Madrid had agreed to open Morocco’s land borders with two Spanish enclaves.
The two countries “have reached a final agreement to open land borders with Ceuta and Melilla in the coming days,” Spanish Foreign Minister José Manuel Albarez told reporters in the Moroccan city of Marrakech, without setting a specific date.
The move helps draw a line under a major diplomatic standoff over coronavirus-related restrictions that have combined to shut down crossings for two years.
J&J Vaccine Benefits
Meanwhile, the South African Health Products Regulatory Authority (Sahpra) reports that The benefits of the J&J vaccine in preventing Covid-19 far outweigh the risks.
Two patients with thrombosis or thrombocytopenia syndrome (TTS) fully recovered after receiving the J&J Covid-19 vaccine.
Of the more than 8.5 million people who received the vaccine in South Africa, only four cases of TTS have been reported. Sahpra said:
“The risk of TTS is addressed in the Approved Professional Information (PI) and Patient Information Leaflet (PIL),” SAHPRA said in a statement.